Literature DB >> 15937763

Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study.

J Gavalda1, O Len, R San Juan, J M Aguado, J Fortun, C Lumbreras, A Moreno, P Munoz, M Blanes, A Ramos, G Rufi, M Gurgui, J Torre-Cisneros, M Montejo, M Cuenca-Estrella, J L Rodriguez-Tudela, A Pahissa.   

Abstract

BACKGROUND: To facilitate the design of strategies for prevention of invasive aspergillosis in solid-organ transplant recipients, this study investigates whether the development of early-onset and late-onset aspergillosis are related to different risk factors, thereby distinguishing 2 risk populations for this serious complication.
METHODS: A retrospective case-control study was performed, including 156 cases of proven or probable invasive aspergillosis in patients recruited from 11 Spanish centers since the start of the centers' transplantation programs.
RESULTS: Among all patients, 57% had early-onset IA (i.e., occurred during the first 3 months after transplantation). Risk factor analysis in this group identified as significantly associated risk factors a more complicated postoperative period, repeated bacterial infections or cytomegalovirus disease, and renal failure or the need for dialysis. Among patients with late-onset infections (i.e., occurred > 3 months after transplantation), who comprised 43% of cases, the patients at risk were older, were in an overimmunosuppressed state because of chronic transplant rejection or allograft dysfunction, and had posttransplantation renal failure.
CONCLUSIONS: Risk factors in patients with early-onset cases and patients with late-onset cases of posttransplantation invasive aspergillosis are not the same, a fact that could have implications for the preventive approaches used for this infection.

Entities:  

Mesh:

Year:  2005        PMID: 15937763     DOI: 10.1086/430602

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  40 in total

Review 1.  Epidemiology of invasive candidiasis: a persistent public health problem.

Authors:  M A Pfaller; D J Diekema
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

2.  A Multicenter, Randomized, Open-Label Study to Compare Micafungin with Fluconazole in the Prophylaxis of Invasive Fungal Infections in Living-Donor Liver Transplant Recipients.

Authors:  Woo-Hyoung Kang; Gi-Won Song; Sung-Gyu Lee; Kyung-Suk Suh; Kwang-Woong Lee; Nam-Joon Yi; Jae Won Joh; Choon Hyuck David Kwon; Jong Man Kim; Dong Lak Choi; Joo Dong Kim; Myoung Soo Kim
Journal:  J Gastrointest Surg       Date:  2019-05-07       Impact factor: 3.452

3.  Prophylaxis of invasive mycoses in solid organ transplantation.

Authors:  Kyle P Radack; Barbara D Alexander
Journal:  Curr Infect Dis Rep       Date:  2009-11       Impact factor: 3.725

4.  Invasive pulmonary aspergillosis in the ICU: reply to Wichmann et al.

Authors:  Joost Wauters; Katrien Lagrou; Alexander Wilmer; Philippe Jorens; Greet Hermans
Journal:  Intensive Care Med       Date:  2013-01-22       Impact factor: 17.440

5.  Incidence and impact of adverse drug events contributing to hospital readmissions in kidney transplant recipients.

Authors:  Michelle A Arms; James Fleming; Deep B Sangani; Satish N Nadig; John W McGillicuddy; David J Taber
Journal:  Surgery       Date:  2017-11-22       Impact factor: 3.982

Review 6.  Infections after orthotopic liver transplantation.

Authors:  Mark Pedersen; Anil Seetharam
Journal:  J Clin Exp Hepatol       Date:  2014-07-24

Review 7.  Host genetics of invasive Aspergillus and Candida infections.

Authors:  Agnieszka Wójtowicz; Pierre-Yves Bochud
Journal:  Semin Immunopathol       Date:  2014-11-18       Impact factor: 9.623

8.  Use of mycological, nested PCR, and real-time PCR methods on BAL fluids for detection of Aspergillus fumigatus and A. flavus in solid organ transplant recipients.

Authors:  Hossein Zarrinfar; Hossein Mirhendi; Koichi Makimura; Kazuo Satoh; Hossein Khodadadi; Omolbanin Paknejad
Journal:  Mycopathologia       Date:  2013-09-18       Impact factor: 2.574

Review 9.  Approach to the Solid Organ Transplant Patient with Suspected Fungal Infection.

Authors:  Judith A Anesi; John W Baddley
Journal:  Infect Dis Clin North Am       Date:  2015-12-28       Impact factor: 5.982

10.  Caspofungin for post solid organ transplant invasive fungal disease: results of a retrospective observational study.

Authors:  M Winkler; J Pratschke; U Schulz; S Zheng; M Zhang; W Li; M Lu; D Sgarabotto; G Sganga; P Kaskel; S Chandwani; L Ma; J Petrovic; M Shivaprakash
Journal:  Transpl Infect Dis       Date:  2010-01-11       Impact factor: 2.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.